Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02218177
What this trial is testing

Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 30
Testing effectiveness (Phase 2)Study completedNCT05891548
What this trial is testing

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 60
Large-scale testing (Phase 3)Study completedNCT03823300
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 658
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Large-scale testing (Phase 3)UnknownNCT05480293
What this trial is testing

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 446
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798375
What this trial is testing

Evaluate the Efficacy and Safety of VIS-101 in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration(nAMD)
Everest Medicines (China) Co.,Ltd. 244
Not applicableNot Yet RecruitingNCT06759597
What this trial is testing

The Effect of Phacoemulsification on the Macular Changes in Patients with Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (wet) Age-Related Macular Degeneration
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT03362190
What this trial is testing

ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Ophthotech Corporation 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178249
What this trial is testing

Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD

Who this might be right for
Wet Age-related Macular Degeneration
Guangzhou Jiayin Biotech Ltd 60
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Large-scale testing (Phase 3)UnknownNCT04667039
What this trial is testing

Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®

Who this might be right for
Age Related Macular Degeneration (ARMD)
AO GENERIUM 408
Testing effectiveness (Phase 2)Study completedNCT05381948
What this trial is testing

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
EyePoint Pharmaceuticals, Inc. 161
Early research (Phase 1)Study completedNCT00109499
What this trial is testing

Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
GenVec
Early research (Phase 1)Study completedNCT04884399
What this trial is testing

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Who this might be right for
Wet Age-related Macular Degeneration
Shanghai Biomabs Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT02571972
What this trial is testing

Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.

Who this might be right for
Wet Macular DegenerationAge-related Macular DegenerationDiabetic Macular Edema+1 more
Wills Eye 14
Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Not applicableUnknownNCT04177069
What this trial is testing

Evaluate the Improving Effects of Visucomplex Plus on Quality of Life in Patients With AMD

Who this might be right for
AMD
VISUfarma SpA 160
Testing effectiveness (Phase 2)Ended earlyNCT01025232
What this trial is testing

Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascular MembraneSubfoveal Neovascular Age-Related Macular Degeneration+2 more
David M. Brown, M.D. 88
Large-scale testing (Phase 3)Study completedNCT06190093
What this trial is testing

A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-related Macular DegenerationAge-Related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 400
Not applicableStudy completedNCT05111743
What this trial is testing

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,261
Next Page